Alvotech (ALVO) – Investment Analysts’ Weekly Ratings Changes

Several analysts have recently updated their ratings and price targets for Alvotech (NASDAQ: ALVO):

  • 11/15/2026 – Alvotech was upgraded by Wall Street Zen from “sell” to “hold”.
  • 11/10/2026 – Alvotech is now covered by Jefferies Financial Group. They set a “buy” rating and a $9.00 price target on the stock.
  • 11/7/2026 – Alvotech was downgraded by Wall Street Zen from “hold” to “sell”.
  • 11/4/2026 – Alvotech was upgraded by Weiss Ratings from “sell (e+)” to “sell (d-)”.
  • 10/24/2026 – Alvotech was upgraded by Wall Street Zen from “sell” to “hold”.
  • 10/23/2026 – Alvotech was downgraded by Weiss Ratings from “sell (d-)” to “sell (e+)”.
  • 10/20/2026 – Alvotech was downgraded by Zacks Research from “hold” to “strong sell”.
  • 10/6/2026 – Alvotech was upgraded by Weiss Ratings from “sell (e+)” to “sell (d-)”.

Alvotech Stock Performance

Shares of ALVO stock opened at $4.37 on Wednesday. Alvotech has a 1 year low of $2.94 and a 1 year high of $6.53. The business’s fifty day moving average is $5.20 and its 200-day moving average is $4.19. The stock has a market cap of $1.32 billion, a PE ratio of -5.33 and a beta of 0.24.

Alvotech (NASDAQ:ALVO – Get Free Report) last announced its quarterly earnings data on Wednesday, November 11th. The company reported ($0.03) earnings per share for the quarter, meeting the consensus estimate of ($0.03). The firm had revenue of $111.60 million during the quarter, compared to analyst estimates of $123.45 million. Equities research analysts predict that Alvotech will post -0.04 earnings per share for the current year.

Alvotech is a biopharmaceutical company based in Reykjavik, Iceland, focused on developing and manufacturing biosimilars—medicines designed to be highly similar to existing biologic drugs. Its work includes biosimilars for conditions in areas such as immunology and oncology. Founded in 2013 by entrepreneur Robert Wessman, the company operates an integrated development and manufacturing platform in Iceland. Alvotech works with commercial partners to seek regulatory approval for and distribute its products in markets including the United States and Europe.

Featured Articles

Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.